Profusa urges shareholders to vote for all proposals at annual meeting Jun 10, 2026 08:02AM
Profusa transfers listing to Nasdaq Capital Market May 15, 2026 07:31AM
Profusa initiates strategic review to evaluate potential transactions May 5, 2026 08:31AM
profusa (PFSA) files for 179.27M share offering by selling stockholders May 1, 2026 03:31PM
Profusa signs $30M letter of intent to acquire diagnostics platform Apr 6, 2026 06:00AM


Feb 27, 2026 09:16AM Profusa withdraws $15 million public offering for smaller fundraise
Feb 19, 2026 08:32AM Profusa raises 2026 revenue guidance after receiving European orders
Feb 12, 2026 04:30PM Profusa partners with Mayo Clinic on oxygen monitoring technology
Jan 16, 2026 07:31AM Profusa launches tissue oxygen monitoring for research market
Dec 31, 2025 07:30AM Profusa adds French distributor MedSell to expand European reach
Dec 30, 2025 07:30AM Profusa restructures convertible notes with higher conversion price
Dec 15, 2025 07:31AM Profusa study shows tissue oxygen sensor meets safety goals
Oct 30, 2025 07:30AM Profusa projects $250 million revenue by 2030 with biosensor launches
Oct 28, 2025 08:33AM Profusa completes manufacturing build-out for early 2026 product launch
Oct 22, 2025 08:32AM Profusa signs European distributor for Lumee oxygen monitoring platform
Oct 7, 2025 08:15AM Profusa invests additional $1 million in bitcoin treasury assets
Oct 1, 2025 08:33AM Profusa adds French surgeon to customer base for oxygen monitoring
Sep 11, 2025 08:30AM Profusa partners with NVIDIA to develop AI-powered biomarker portal
Aug 19, 2025 08:15AM Profusa adds former VA secretary and Fortune 500 CFO to leadership
Aug 11, 2025 06:07AM Profusa (PFSA) Files for 8.97M Share Offering by Selling Stockholders
Aug 6, 2025 08:16AM Profusa outlines five-pillar growth strategy following NASDAQ debut
Jul 31, 2025 08:15AM Profusa signs distribution agreement for Lumee Oxygen platform in Spain
Jul 11, 2025 04:00PM Profusa completes SPAC merger, begins trading on NASDAQ Monday